Cargando…

Peer support for patients with type 2 diabetes: cluster randomised controlled trial

Objective To test the effectiveness of peer support for patients with type 2 diabetes. Design Cluster randomised controlled. Setting 20 general practices in the east of the Republic of Ireland. Participants 395 patients (192 in intervention group, 203 in control group) and 29 peer supporters with ty...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, S M, Paul, G, Kelly, A, Whitford, D L, O’Shea, E, O’Dowd, T
Formato: Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3039437/
https://www.ncbi.nlm.nih.gov/pubmed/21324992
http://dx.doi.org/10.1136/bmj.d715
_version_ 1782198183578828800
author Smith, S M
Paul, G
Kelly, A
Whitford, D L
O’Shea, E
O’Dowd, T
author_facet Smith, S M
Paul, G
Kelly, A
Whitford, D L
O’Shea, E
O’Dowd, T
author_sort Smith, S M
collection PubMed
description Objective To test the effectiveness of peer support for patients with type 2 diabetes. Design Cluster randomised controlled. Setting 20 general practices in the east of the Republic of Ireland. Participants 395 patients (192 in intervention group, 203 in control group) and 29 peer supporters with type 2 diabetes. Intervention All practices introduced a standardised diabetes care system. The peer support intervention ran over a two year period and contained four elements: the recruitment and training of peer supporters, nine group meetings led by peer supporters in participant’s own general practice, and a retention plan for the peer supporters. Main outcome measures HbA(1c); cholesterol concentration; systolic blood pressure; and wellbeing score. Results There was no difference between intervention and control patients at baseline. All practices and 85% (337) of patients were followed up. At two year follow-up, there were no significant differences in HbA(1c) (mean difference −0.08%, 95% confidence interval −0.35% to 0.18%), systolic blood pressure (−3.9 mm Hg, −8.9 to 1.1 mm Hg), total cholesterol concentration (−0.03 mmol/L, −0.28 to 0.22 mmol/L), or wellbeing scores (−0.7, −2.3 to 0.8). While there was a trend towards decreases in the proportion of patients with poorly controlled risk factors at follow-up, particularly for systolic blood pressure (52% (87/166) >130 mm Hg in intervention v 61% (103/169) >130 mm Hg in control), these changes were not significant. The process evaluation indicated that the intervention was generally delivered as intended, though 18% (35) of patients in the intervention group never attended any group meetings. Conclusions A group based peer support intervention is feasible in general practice settings, but the intervention was not effective when targeted at all patients with type 2 diabetes. While there was a trend towards improvements of clinical outcomes, the results do not support the widespread adoption of peer support. Trial registration Current Controlled Trials ISRCTN42541690.
format Text
id pubmed-3039437
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BMJ Publishing Group Ltd.
record_format MEDLINE/PubMed
spelling pubmed-30394372011-02-23 Peer support for patients with type 2 diabetes: cluster randomised controlled trial Smith, S M Paul, G Kelly, A Whitford, D L O’Shea, E O’Dowd, T BMJ Research Objective To test the effectiveness of peer support for patients with type 2 diabetes. Design Cluster randomised controlled. Setting 20 general practices in the east of the Republic of Ireland. Participants 395 patients (192 in intervention group, 203 in control group) and 29 peer supporters with type 2 diabetes. Intervention All practices introduced a standardised diabetes care system. The peer support intervention ran over a two year period and contained four elements: the recruitment and training of peer supporters, nine group meetings led by peer supporters in participant’s own general practice, and a retention plan for the peer supporters. Main outcome measures HbA(1c); cholesterol concentration; systolic blood pressure; and wellbeing score. Results There was no difference between intervention and control patients at baseline. All practices and 85% (337) of patients were followed up. At two year follow-up, there were no significant differences in HbA(1c) (mean difference −0.08%, 95% confidence interval −0.35% to 0.18%), systolic blood pressure (−3.9 mm Hg, −8.9 to 1.1 mm Hg), total cholesterol concentration (−0.03 mmol/L, −0.28 to 0.22 mmol/L), or wellbeing scores (−0.7, −2.3 to 0.8). While there was a trend towards decreases in the proportion of patients with poorly controlled risk factors at follow-up, particularly for systolic blood pressure (52% (87/166) >130 mm Hg in intervention v 61% (103/169) >130 mm Hg in control), these changes were not significant. The process evaluation indicated that the intervention was generally delivered as intended, though 18% (35) of patients in the intervention group never attended any group meetings. Conclusions A group based peer support intervention is feasible in general practice settings, but the intervention was not effective when targeted at all patients with type 2 diabetes. While there was a trend towards improvements of clinical outcomes, the results do not support the widespread adoption of peer support. Trial registration Current Controlled Trials ISRCTN42541690. BMJ Publishing Group Ltd. 2011-02-15 /pmc/articles/PMC3039437/ /pubmed/21324992 http://dx.doi.org/10.1136/bmj.d715 Text en © Smith et al 2011 This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.
spellingShingle Research
Smith, S M
Paul, G
Kelly, A
Whitford, D L
O’Shea, E
O’Dowd, T
Peer support for patients with type 2 diabetes: cluster randomised controlled trial
title Peer support for patients with type 2 diabetes: cluster randomised controlled trial
title_full Peer support for patients with type 2 diabetes: cluster randomised controlled trial
title_fullStr Peer support for patients with type 2 diabetes: cluster randomised controlled trial
title_full_unstemmed Peer support for patients with type 2 diabetes: cluster randomised controlled trial
title_short Peer support for patients with type 2 diabetes: cluster randomised controlled trial
title_sort peer support for patients with type 2 diabetes: cluster randomised controlled trial
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3039437/
https://www.ncbi.nlm.nih.gov/pubmed/21324992
http://dx.doi.org/10.1136/bmj.d715
work_keys_str_mv AT smithsm peersupportforpatientswithtype2diabetesclusterrandomisedcontrolledtrial
AT paulg peersupportforpatientswithtype2diabetesclusterrandomisedcontrolledtrial
AT kellya peersupportforpatientswithtype2diabetesclusterrandomisedcontrolledtrial
AT whitforddl peersupportforpatientswithtype2diabetesclusterrandomisedcontrolledtrial
AT osheae peersupportforpatientswithtype2diabetesclusterrandomisedcontrolledtrial
AT odowdt peersupportforpatientswithtype2diabetesclusterrandomisedcontrolledtrial